MedPath
TGA Approval

FABRAZYME agalsidase beta - rch 5.5mg powder for injection vial (94000)

94000

FABRAZYME agalsidase beta - rch 5.5mg powder for injection vial

Sanofi-Aventis Australia Pty Ltd

April 14, 2003

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/9850611c3eb31fb3861c62eb40c55a5f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7d1e1c28c833b2b6f61b41863282a8d4.pdf

Active Ingredients

Agalsidase beta

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.